| |
| Human Gene/Protein |
| Cytogaligin | 9.0 | |
| KIAA1024L | 9.0 | |
| LOC644246 | 9.0 | |
| DRD5P1 | 9.0 | |
| Parkinson disease (autosomal recessive, juvenile) 2, parkin | 9.0 | |
| bridging integrator 3 | 9.0 | |
| Roco1 | 9.0 | |
| ZCRB1 | 9.0 | |
| centaurin beta5 | 9.0 | |
| FGF20 protein | 9.0 | |
| DnaJ (Hsp40) homolog, subfamily C, member 13 | 9.0 | |
| discs, large (Drosophila) homolog-associated protein 3 | 9.0 | |
| F-box only protein 48 | 9.0 | |
| C20orf24 | 9.0 | |
| PRR18 | 9.0 | |
| TOMM7 | 9.0 | |
| DRD5P2 | 9.0 | |
| CENTB5 | 9.0 | |
| Neurofilament-light | 9.0 | |
| Coiled-coil domain-containing protein 154 | 9.0 | |
| PTPDC1 | 9.0 | |
| EIF4G1 protein | 9.0 | |
| signal peptide peptidase-like 2B | 9.0 | |
| ZSCAN21 | 9.0 | |
| ZSCAN21 protein | 9.0 | |
| C2orf58 | 9.0 | |
| musashi 1 | 9.0 | |
| GIGYF2 protein | 9.0 | |
| Cyclin G associated kinase | 9.0 | |
| FLJ43860 | 9.0 | |
| neuron specific transcription factor | 9.0 | |
| OR9A2 | 9.0 | |
| tyrosine hydroxylase isoform 2 | 9.0 | |
| FLJ35379 | 9.0 | |
| synphilin-1A | 9.0 | |
| DHX57 | 9.0 | |
| FAM171A2 | 9.0 | |
| OR52L1 | 9.0 | |
| metallopeptidase M20 family | 9.0 | |
| zinc finger with KRAB and SCAN domains 3 | 9.0 | |
| LRRC37A2 | 9.0 | |
| DENND2A | 9.0 | |
| FLJ45455 | 9.0 | |
| nuclear undecaprenyl pyrophosphate synthase 1 homolog | 9.0 | |
| CDCP2 | 9.0 | |
| AMPK beta 1 | 9.0 | |
| peroxisomal biogenesis factor 3 | 9.0 | |
| parkin isoform | 9.0 | |
| EFHA2 | 9.0 | |
| serine/threonine kinase 32B | 9.0 | |
| RAB7, member RAS oncogene family-like 1 | 9.0 | |
| non-SMC condensin I complex, subunit D2 | 9.0 | |
| transmembrane protein 175 | 9.0 | |
| PARK8 | 8.9 | |
| leucine-rich repeat kinase 2 | 8.9 | |
| Leucine-rich repeat kinase 2 | 8.9 | |
| ZNF746 | 8.8 | |
| LRRK2 | 8.8 | |
| Synphilin-1 | 8.8 | |
| SNCA | 8.7 | |
| synphilin-1 | 8.7 | |
| DNAJC13 | 8.7 | |
| Alpha synuclein | 8.6 | |
| RAB7L1 | 8.6 | |
| zinc finger protein 746 | 8.6 | |
| Dopamine receptor D3 | 8.6 | |
| Synaptotagmin XI | 8.6 | |
| alpha-synuclein | 8.5 | |
| PARK6 | 8.5 | |
| parkin | 8.5 | |
| alpha synuclein | 8.5 | |
| synuclein | 8.5 | |
| ATP13A2 | 8.5 | |
| RAB29 | 8.4 | |
| DCAKD | 8.4 | |
| Kufor-Rakeb syndrome | 8.4 | |
| PARK7 | 8.4 | |
| FBXO7 | 8.3 | |
| beta-synuclein | 8.3 | |
| SYT11 | 8.3 | |
| CHCHD2 | 8.3 | |
| DJ-1 | 8.3 | |
| LRRC37A | 8.2 | |
| PARK11 | 8.2 | |
| RILPL1 | 8.2 | |
| F-box only protein 7 | 8.2 | |
| vacuolar protein sorting 35 | 8.2 | |
| PARK2 | 8.2 | |
| PINK1 | 8.2 | |
| TMEM175 | 8.2 | |
| ATP13A2 protein | 8.2 | |
| ZNF184 | 8.2 | |
| SNCB | 8.2 | |
| SNCAIP | 8.2 | |
| LRRK1 | 8.2 | |
| PARKIN | 8.1 | |
| RAB39B | 8.1 | |
| STN | 8.0 | |
| GBA1 | 8.0 | |
| conserved dopamine neurotrophic factor | 8.0 | |
| BBG-TCC | 8.0 | |
| synaptotagmin XI | 8.0 | |
| PACE-1 | 8.0 | |
| RIMS3 | 8.0 | |
| sideroflexin 3 | 8.0 | |
| UBL4B | 8.0 | |
| ubiquitin specific peptidase 24 | 8.0 | |
| XAP3 | 8.0 | |
| complement component 4B | 8.0 | |
| ACTR1B | 8.0 | |
| Contactin-associated protein-like 4 | 8.0 | |
| SEC14L4 | 8.0 | |
| TUBA6 | 8.0 | |
| interferon gamma-inducible protein 30 | 8.0 | |
| OVOS2 | 8.0 | |
| EIF4G1 | 8.0 | |
| calsyntenin 1 | 8.0 | |
| OR11H1 | 8.0 | |
| protein FAM134A | 8.0 | |
| low density lipoprotein receptor-related protein 10 | 8.0 | |
| EFCAB5 | 8.0 | |
| ATP13A5 | 8.0 | |
| OR1D5 | 8.0 | |
| Nuclear receptor subfamily 4, group A, member 2 | 8.0 | |
| MICS1 | 8.0 | |
| hemoglobin delta | 8.0 | |
| OR10A4 | 8.0 | |
| OR51B6 | 8.0 | |
| KIAA1026 | 8.0 | |
| ERP60 | 8.0 | |
| ORM2 protein | 8.0 | |
| PARK13 | 8.0 | |
| HGMP071 | 8.0 | |
| ATP5SL | 8.0 | |
| SIPA1L2 | 8.0 | |
| GPRIN3 | 8.0 | |
| BCL2-associated athanogene 5 | 8.0 | |
| RHOT2 | 8.0 | |
| Reticulon 2 | 8.0 | |
| RNF19 | 8.0 | |
| palate, lung and nasal epithelium associated | 8.0 | |
| HCLS1 binding protein 3 | 8.0 | |
| ubiquitin specific peptidase 10 | 8.0 | |
| Prion-like protein | 8.0 | |
| SPTLC1 protein | 8.0 | |
| DBNDD1 | 8.0 | |
| endosulfine alpha | 8.0 | |
| ubiquitin carboxy-terminal esterase | 8.0 | |
| Microtubule-actin crosslinking factor 1 | 8.0 | |
| ZNF467 | 8.0 | |
| MPP | 8.0 | |
| Parkin | 8.0 | |
| GIGYF2 | 7.9 | |
| PITX3 | 7.9 | |
| ACMSD | 7.9 | |
| gamma-synuclein | 7.9 | |
| VPS13C | 7.9 | |
| VPS35 | 7.9 | |
| BST1 | 7.8 | |
| paired-like homeodomain transcription factor 3 | 7.8 | |
more... | | more... | | more... | | more... | | more... | |
| Compound |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| C9H9NO7 | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| DNPD | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| 1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| C20H16N2O | 9.0 | |
| 2-(4-methylphenyl)-1H-indole | 9.0 | |
| 2-(4-methylphenyl)-1H-indole | 9.0 | |
| Carbidopa-levodopa | 8.6 | |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 8.3 | |
| Ropinirole | 8.3 | |
| MPTP | 8.3 | |
| Entacapone | 8.3 | |
| 1-benzyl-1,2,3,4-tetrahydroisoquinoline | 8.3 | |
| 2-benzylidene-1-indanone | 8.2 | |
| Tolcapone | 8.2 | |
| Selegiline | 8.1 | |
| PDQ | 8.1 | |
| 1-Methyl-4-phenylpyridinium | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| Deoxygedunin | 8.0 | |
| C19H17NO4 | 8.0 | |
| C19H17NO4 | 8.0 | |
| 4-phenylbutanamide | 8.0 | |
| C19H17NO4 | 8.0 | |
| gamma-Fagarine | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C19H17NO4 | 8.0 | |
| 2-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | 8.0 | |
| Biperiden hydrochloride | 8.0 | |
| 3,4-Dihydroxyphenylacetaldehyde | 8.0 | |
| C19H17NO4 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C19H17NO4 | 8.0 | |
| 1-benzyl-3,4-dihydroisoquinoline | 8.0 | |
| C19H17NO4 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C19H17NO4 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| C10H10ClNO2 | 8.0 | |
| 1-chloroisoquinoline | 8.0 | |
| C19H17NO4 | 8.0 | |
| MPP | 7.9 | |
| MPP | 7.9 | |
| Pergolide | 7.8 | |
| 4-phenyl-1,2,3,6-tetrahydropyridine | 7.8 | |
| DBS | 7.7 | |
| 1-methyl-1,2,3,6-tetrahydropyridine | 7.6 | |
| 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline | 7.4 | |
| C19H17NO4 | 7.4 | |
| C19H17NO4 | 7.4 | |
| Vasicinone | 7.4 | |
| Oxiperomide | 7.4 | |
| Lycopodine | 7.4 | |
| C19H17NO4 | 7.4 | |
| N-Methyl-(R)-salsolinol | 7.4 | |
| N(epsilon)-(gamma-glutamyl)-lysine | 7.4 | |
| 5-Hydroxydopamine | 7.4 | |
| C19H17NO4 | 7.4 | |
| 2,6-dimethyl-3,5-pyridinedicarboxylic acid | 7.4 | |
| C21H15N3O2 | 7.4 | |
| C19H17NO4 | 7.4 | |
| C21H19N3O3S | 7.4 | |
| Norlichexanthone | 7.4 | |
| 2,6-dimethyl-3,5-pyridinedicarboxylic acid | 7.4 | |
| L-DOPA | 7.3 | |
| 1,2,3,6-tetrahydropyridine | 7.2 | |
| 1,2,3,6-tetrahydropyridine | 7.2 | |
| 6-Hydroxydopamine | 7.2 | |
| 2-anilinobenzamide | 7.2 | |
| Rotenone | 7.2 | |
| 4-phenylpyridine | 7.1 | |
| ethyl methylcarbamate | 7.1 | |
| C20H22N2O2 | 7.0 | |
| MPDP | 7.0 | |
| XCT 790 | 7.0 | |
| C13H17NO2 | 7.0 | |
| Rutacridone epoxide | 7.0 | |
| Rhododendrin | 7.0 | |
| EADB | 7.0 | |
| Apomorphine hydrochloride | 6.9 | |
| CGP 28014 | 6.8 | |
| Amantadine | 6.7 | |
| Amantadine | 6.7 | |
| Cabergoline | 6.7 | |
| C15H12ClNO | 6.7 | |
| C8H8N2 | 6.7 | |
| N-Methylsalsolinol | 6.7 | |
| Amantadine | 6.6 | |
| Zonisamide | 6.5 | |
| Stylopine | 6.4 | |
| Stylopine | 6.4 | |
| arginine succinate | 6.4 | |
| Cannabichromene | 6.4 | |
| Tambulin | 6.4 | |
| 24-Hydroxycholesterol | 6.4 | |
| C19H22N2O4 | 6.4 | |
| C10H16O2 | 6.4 | |
| 1-hepten-3-ol | 6.4 | |
| Dopa | 6.3 | |
| Maneb | 6.3 | |
| BSSG | 6.3 | |
| Amantadine | 6.3 | |
| C16H14O2 | 6.2 | |
| 1-propylpiperidine | 6.2 | |
| Propargylamine | 6.2 | |
| Ro 61-8048 | 6.2 | |
| Neriifolin | 6.2 | |
| Rivastigmine | 6.1 | |
| 1,2,3,4-tetrahydroisoquinoline | 6.1 | |
| Trihexyphenidyl | 6.0 | |
| 3,4-dihydroxyphenylalanine | 6.0 | |
| 1-benzhydrylpiperazine | 6.0 | |
| allyl carbamate | 6.0 | |
| C17H17NO4 | 6.0 | |
| 3-Chlorotyrosine | 6.0 | |
| Panaxatriol | 6.0 | |
| 2-methyl-1,2,3,4-tetrahydroquinoline | 6.0 | |
| Dopamine | 5.9 | |
| Paraquat | 5.8 | |
| Azure C | 5.8 | |
| Chloral | 5.8 | |
| 1-benzhydrylpiperazine | 5.8 | |
| 8,9-epoxyeicosatrienoic acid | 5.8 | |
| DAT | 5.8 | |
| DAQ | 5.7 | |
| Paraquat | 5.7 | |
| CIT | 5.7 | |
| 5-phenylisoxazole | 5.7 | |
| MIF-I | 5.7 | |
| Tetrahydrocoptisine | 5.7 | |
| Tubeimoside I | 5.7 | |
| Orphenadrine | 5.6 | |
| Methylxanthine | 5.6 | |
| CIT | 5.6 | |
| 4-chlorobenzamide | 5.6 | |
| Thioflavine S | 5.6 | |
more... |